Phase 2 randomized double-blind placebo-controlled six weeks study of the efficacy and safety of tofimilast dry powder for inhalation in adults diagnosed with chronic obstructive pulmonary disease
Latest Information Update: 19 Nov 2012
At a glance
- Drugs Tofimilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Dec 2005 New trial record.